You Lost The Weight. Did You Lose The Wrong Kind?

by team nuut

The number nobody tells you about GLP-1 weight loss.

You drop 10 kilos, your jeans finally close without a fight and the scale gives you the number you've wanted for years.

 

Then you try to carry the groceries upstairs, and your legs feel weaker than they should.

Nobody warned you about this part.

 

GLP-1 medications are genuinely changing how people lose weight, faster, and often more sustainably, than diet alone. But the body doesn't only lose "bad weight." Depending on how you eat, train and recover, a real chunk of that loss can come from lean tissue, the muscle and fat-free mass that keeps you strong, mobile and metabolically healthy.

 

In the landmark STEP 1 trial, Wilding and colleagues found that adults taking once-weekly semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks, alongside lifestyle intervention, compared with 2.4% on placebo.

 

That trial helped change obesity medicine. It also raised a question that matters for anyone using a GLP-1, thinking about starting one, or trying to hold onto their results after finishing: when the number on the scale drops that fast, what's being lost?

 

A follow-up STEP 1 sub-study went looking for the answer. Researchers scanned 140 of the original participants with DEXA, the gold-standard body composition scan, at the start of the trial and again at week 68. The result was encouraging but not simple: semaglutide reduced fat mass substantially, and on average, people also lost around 5.8kg of lean body mass along the way.

That doesn't mean GLP-1 medications are "bad for muscle." It means the medication is only one part of the transformation. The habits built around it decide whether the result feels stronger, flatter, more capable, or quietly depleted.

 

The goal was never to end up smaller and weaker. It's to lose the fat and keep the muscle that lets you live well in the body you've worked for.

The Scale Can Drop While Your Strength Drops Too

A scale is useful, but it's blunt. It can't tell you whether the kilo you lost this week was fat, water, glycogen, or lean tissue.

 

Two people can lose the same 10kg and end up in very different places. One is eating enough protein, lifting a couple of times a week, sleeping properly, and holding onto most of their strength. The other is barely eating, skipping training because energy is low, and celebrating the same number on the scale while quietly losing the tissue that makes everyday life easier, carrying groceries, taking stairs, getting up off the floor without thinking about it.

 

The difference isn't willpower. It's structure.

 

The tirzepatide data tells a similar story. In the SURMOUNT-1 trial, Jastreboff and colleagues reported in 2022 that adults with obesity or overweight taking tirzepatide achieved substantial weight loss over 72 weeks. A later body-composition analysis of that same trial found the loss included both fat and lean mass, fat made up the larger share, which is good news, but lean mass still declined.

 

So even when most of what's lost is fat, muscle can still be part of the bill. "How much weight did you lose?" isn't really the useful question anymore. It's "what kind of weight did you lose?"

 

Muscle matters well beyond how you look. It supports your strength, your blood sugar regulation, your posture, your balance, and your independence as you get older. Losing fat can improve your health. Losing too much muscle alongside it can make the result feel a lot less powerful than the scale suggests.

Why Protein Gets Harder To Hit Exactly When You Need It Most

GLP-1 medications can make eating less feel almost effortless, for a lot of people, that's the whole appeal. But a quieter problem tends to show up a few weeks in: meals get smaller, protein portions shrink, breakfast becomes a coffee, dinner becomes half a plate because fullness arrives fast.

 

The scale might keep rewarding the pattern, so it feels like it's working. But from your muscle's point of view, the day may be underbuilt.

 

Protein is the raw material your body uses to repair and hold onto lean tissue. The 2017 International Society of Sports Nutrition position stand (Jäger et al.) found that resistance exercise and protein intake work together to support muscle protein synthesis, and pointed to somewhere in the range of 1.4–2.0g of protein per kilo of bodyweight per day for people who are training, depending on their goals.

 

That doesn't mean everyone on a GLP-1 needs to eat like an athlete. It means protein must be planned for, not left to chance, because when appetite drops away, it's usually the first thing to slip.

The Other Half of The Equation: Giving Your Muscle A Reason To Stay

Protein gives your body the materials. Resistance training gives it a reason to use them.

 

Walking and daily movement both counts. But if the goal is holding onto muscle specifically, progressive resistance training is the clearest signal your body responds to. 

 

A 2018 systematic review and meta-analysis in Nutrients (Sardeli et al.) looked at older adults with obesity in a calorie deficit and found that resistance training helped protect against the muscle loss that calorie restriction alone caused.

 

That matters here because GLP-1 medications can create a calorie-deficit state fast. If your body gets the message "less food is coming in, and nothing is asking us to stay strong," muscle becomes easier to let go of. If it gets the message "we still need this," it has a much stronger reason to hold on.

 

And the two work best together, a 2018 meta-analysis in the British Journal of Sports Medicine (Morton et al.) found that protein supplementation measurably improved the muscle and strength gains people got from resistance training. Lift enough to send the signal, eat enough protein to back it up.

Where glo_up_1 Fits Into Your GLP-1 Journey

This is the gap glo_up_1 was formulated to close, not a replacement for eating well or moving your body, but daily support for the part that gets hardest exactly when appetite disappears: getting enough protein in, consistently, without a fight.

 

Each shake delivers:

  • 35g of protein per serve - a serious dose, without needing a big appetite to get there
  • 6g of collagen peptides, alongside the plant protein, to round out your amino acid intake
  • L-carnitine and MCT oil, formulated to support energy and muscle maintenance during a calorie deficit
  • A full spread of vitamins and minerals, so a smaller appetite doesn't quietly turn into a nutrient gap
  • Only ~202 calories, so it works with your goals instead of against them

 

If nausea, early fullness, or a smaller appetite makes big meals hard to get through, relying on one large evening meal for your daily protein is a plan that often fails simply because you can't comfortably finish it. Smaller, protein-anchored moments across the day, glo_up_1 being one of them, tend to be far easier to actually stick to.

 

Available in rich chocolate and vanilla brûlée, because supporting your muscle shouldn't taste like a compromise.

 

A useful checkpoint: if the scale keeps dropping but your lifts are collapsing, stairs feel harder, and your energy is consistently flat, that's worth paying attention to.

The Bottom Line

GLP-1 medications can help people lose weight at a level that once felt out of reach. But the better goal is not just a lower number.

 

It is a stronger result: less fat, better habits, preserved strength, and a body that still performs when the scale is no longer the only thing being measured.

 

That is where glo_up_1 earns its place in the routine. When appetite is lower, and meals feel smaller, glo_up_1 offers an easy daily way to hit your protein target and support the consistency that helps keep strength in the picture.

 

Try the glo_up_1 taster pack and see how it fits into your routine.

This article is general information, not medical advice. Always talk to your doctor or healthcare provider about what's right for you, especially if you're taking GLP-1 medication.

 

Sources Wilding, J.P.H. et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. Wilding, J.P.H. et al. (2021). Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society, 5(Suppl_1), A16–A17. Jastreboff, A.M. et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 387(3), 205–216. Jäger, R. et al. (2017). International Society of Sports Nutrition Position Stand: Protein and Exercise. Journal of the International Society of Sports Nutrition, 14(20). Sardeli, A.V. et al. (2018). Resistance Training Prevents Muscle Loss Induced by Caloric Restriction in Obese Elderly Individuals: A Systematic Review and Meta-Analysis. Nutrients, 10(4), 423. Morton, R.W. et al. (2018). A Systematic Review, Meta-Analysis and Meta-Regression of the Effect of Protein Supplementation on Resistance Training-Induced Gains in Muscle Mass and Strength in Healthy Adults. British Journal of Sports Medicine, 52(6), 376–384.